Delivery Order SPE2DR25D1041-SPE2DR26FHS8Z
Award Date 4/9/26
Potential Completion Date 4/10/26
Potential Value $2.6K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency issued a $4,978.06 delivery order to Amerisourcebergen Drug Corp on April 8, 2026, for Quillivant XR 25 mg/5 ml suspension (180 ml), with ultimate completion on April 9, 2026. The order is issued under the DLA Troop Support Medical indefinite delivery contract (SPE2DX), a $999,999,999 vehicle through December 2026 that supplies pharmaceutical products and medical supplies to support military healthcare programs globally. Place of performance is Conshohocken, PA....
- The Defense Logistics Agency issued a $1,145.16 delivery order to Amerisourcebergen Drug Corp on March 27, 2026, for Quillivant XR 25 mg/5 ml suspension (60 ml), with an ultimate completion date of March 30, 2026. The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (valued up to $999,999,999 through December 2026), which supplies pharmaceutical products and medical supplies to support military healthcare programs globally. Place of performance is Conshohocken,...
- The Defense Logistics Agency issued a $1,272.40 delivery order to Amerisourcebergen Drug Corp on April 1, 2026, for Quillivant XR 25 mg/5 ml suspension (180 ml). The order is issued under the DLA Troop Support Medical indefinite delivery contract (SPE2DX), a $999,999,999 vehicle through December 2026 that supplies pharmaceutical products and medical supplies to support military healthcare programs globally. Place of performance is Conshohocken, PA. The order is firm fixed price with an...
- The Defense Logistics Agency issued a $1,892.75 delivery order to AmerisourceBergen Drug Corp on April 6, 2026, for Quillivant XR 25 mg/5 ml suspension (180 ml). The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (IDC), valued at up to $999,999,999.00 and running through December 2026. This is a firm fixed-price pharmaceutical supply contract supporting military healthcare programs globally. Place of performance is Conshohocken, PA. Ultimate completion date is...
- The Defense Logistics Agency issued a $4,594.75 delivery order to Amerisourcebergen Drug Corp on March 9, 2026, for Quillivant XR 25 mg/5 ml suspension (180 ml), with an ultimate completion date of March 10, 2026. The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (SPE2DX), valued at $999,999,999.00 through December 2026, which provides global pharmaceutical support to military healthcare programs. Place of performance is Conshohocken, PA. The order carries firm...
- The Defense Logistics Agency issued a $2,073.45 delivery order to Amerisourcebergen Drug Corp on March 20, 2026, for Quillivant XR 25 mg/5 ml suspension (180 ml), with an ultimate completion date of March 23, 2026. The order is issued under the Defense Logistics Agency Troop Support Medical indefinite delivery contract (SPE2DX), valued at up to $999,999,999 through December 2026, which provides pharmaceutical and medical supply support to military healthcare programs globally. Place of...
- The Defense Logistics Agency issued a $2,433.68 delivery order to Amerisourcebergen Drug Corp on March 24, 2026, for Quillivant XR 25 mg/5 ml suspension (180 ml). The order is issued under a parent Indefinite Delivery Contract with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2026, which supports global pharmaceutical supply to military healthcare programs. Place of performance is Conshohocken, PA. The ultimate completion date is March 25, 2026....
- The Defense Logistics Agency issued a $1,516.85 delivery order to Amerisourcebergen Drug Corp on April 6, 2026, for Quillivant XR 25 mg/5 ml suspension (60 ml). The order was issued under the DLA Troop Support Medical Indefinite Delivery Contract (IDC), a $999,999,999 vehicle through December 2026 that supplies pharmaceutical products and medical supplies globally to support military healthcare programs. Place of performance is Conshohocken, PA. The order carries a firm fixed price structure...
- The Defense Logistics Agency issued a $2,248.55 delivery order to Amerisourcebergen Drug Corp on April 7, 2026, for Quillivant XR 25 mg/5 ml suspension (180 ml), with an ultimate completion date of April 8, 2026. The order is issued under a parent Indefinite Delivery Contract with the DLA Troop Support Medical valued at up to $999,999,999.00 through December 2026. This IDC supports global pharmaceutical supply to military healthcare programs, covering specialty medications, brand-name and...
- The Defense Logistics Agency issued a $2,405.02 delivery order to Amerisourcebergen Drug Corp on March 6, 2026, for Quillivant XR 25 mg/5 ml suspension (120 ml). The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (valued at up to $999,999,999.00 through December 2026), which provides pharmaceutical and medical supply support to military healthcare programs globally. Place of performance is Conshohocken, PA. Ultimate completion date is March 9, 2026. Pricing is...
- SPE2DR25D1041Indefinite Delivery Contract
- SPE2DR25D1041-SPE2DR26FHS8ZDelivery Order
The Defense Logistics Agency issued a $2,585.95 delivery order to Amerisourcebergen Drug Corp on April 9, 2026, for Quillivant XR 25 mg/5 ml suspension (180 ml), with an ultimate completion date of April 10, 2026. The order is issued under a firm fixed-price structure with no set-aside. Place of performance is Conshohocken, PA. The order calls against the company's Indefinite Delivery Contract with DLA Troop Support Medical, a comprehensive pharmaceutical supply vehicle valued at up to $999,999,999 through December 2026, which supports military healthcare programs globally.
Generated 7/8/26, 9:55 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.6k | 4/8/26 |